Management of Spinal Emergencies in Patients on Direct Oral Anticoagulants.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 12 05 2019
revised: 30 07 2019
accepted: 31 07 2019
pubmed: 11 8 2019
medline: 28 1 2020
entrez: 11 8 2019
Statut: ppublish

Résumé

Spine surgeons increasingly encounter acute spinal pathologies in patients treated with direct oral anticoagulants (DOACs), but only limited data on the management of these patients are currently available. We retrospectively analyzed patients who presented to our department with acute spinal pathology during treatment with DOAC and who required urgent surgical therapy. Patient characteristics and treatment modalities were studied, with specific focus on the management of hemostasis and surgical therapy. Furthermore, we analyzed 19 cases of spinal emergencies during DOAC treatment reported in the literature. A total of 12 patients were identified and included in the present analysis. Patients suffered from acute spinal cord compression caused by spinal tumor manifestation (n = 5), empyema (n = 4), degenerative spinal stenosis (n = 1), hematoma (n = 1), and vertebral body fracture/dislocation (n = 2). All patients underwent emergency surgical treatment. Prohemostatic substances were administered perioperatively in 10 patients (83%) and included administration of prothrombin complex concentrates (83%), tranexamic acid (17%), and transfusion of platelets (8%). A total of 9 patients (75%) showed postoperative improvement of neurologic symptoms, and the in-hospital mortality in this patient cohort was 17%. Emergency spine surgery is feasible and should be considered in patients on treatment with DOAC. The (low) risk of intraoperative bleeding complications has to be weighed against the risk of permanent disability if surgical decompression is delayed. Administration of prothrombin complex concentrates and tranexamic acid may improve the coagulation before surgery, especially in cases of unavailable specific antidotes.

Identifiants

pubmed: 31400524
pii: S1878-8750(19)32150-3
doi: 10.1016/j.wneu.2019.07.234
pii:
doi:

Substances chimiques

Anticoagulants 0
Antithrombins 0
Blood Coagulation Factors 0
Factor Xa Inhibitors 0
Hemostatics 0
prothrombin complex concentrates 37224-63-8
Tranexamic Acid 6T84R30KC1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e570-e578

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Christopher Beynon (C)

Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: christopher.beynon@med.uni-heidelberg.de.

Arturo Olivares (A)

Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.

Christoph Gumbinger (C)

Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

Alexander Younsi (A)

Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.

Klaus Zweckberger (K)

Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.

Andreas W Unterberg (AW)

Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH